BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 22831484)

  • 1. Challenges and perspectives in anti-doping testing.
    Schamasch P; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1691-701. PubMed ID: 22831484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
    Barroso O; Handelsman DJ; Strasburger C; Thevis M
    Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harmonization of anti-doping rules in a global context (World Anti-Doping Agency-laboratory accreditation perspective).
    Ivanova V; Miller JH; Rabin O; Squirrell A; Westwood S
    Bioanalysis; 2012 Jul; 4(13):1603-11. PubMed ID: 22831476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement uncertainty in anti-doping quantitative analysis for prohibited threshold substances.
    Barroso O; Miller J; Squirrell A; Westwood S
    Bioanalysis; 2012 Jul; 4(13):1653-65. PubMed ID: 22831481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current implementation and future of the Athlete Biological Passport.
    Sottas PE; Vernec A
    Bioanalysis; 2012 Jul; 4(13):1645-52. PubMed ID: 22831480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ensuring high quality in anti-doping laboratories.
    Boghosian T; Barroso O; Ivanova V; Rabin O
    Bioanalysis; 2012 Jul; 4(13):1591-601. PubMed ID: 22831475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of GH abuse in sport: Past, present and future.
    Barroso O; Schamasch P; Rabin O
    Growth Horm IGF Res; 2009 Aug; 19(4):369-74. PubMed ID: 19482501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in Modern Anti-Doping Analytical Science.
    Ayotte C; Miller J; Thevis M
    Med Sport Sci; 2017; 62():68-76. PubMed ID: 28571012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New and old challenges of sports drug testing.
    Botrè F
    J Mass Spectrom; 2008 Jul; 43(7):903-7. PubMed ID: 18570180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical progresses of the International Olympic Committee and World Anti-Doping Agency Olympic laboratories.
    Georgakopoulos C; Saugy M; Giraud S; Robinson N; Alsayrafi M
    Bioanalysis; 2012 Jul; 4(13):1549-63. PubMed ID: 22831472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
    Botrè F; de la Torre X; Donati F; Mazzarino M
    Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and accreditation of anti-doping laboratories for the Olympic Games.
    Botrè F; Wu M; Boghosian T
    Bioanalysis; 2012 Jul; 4(13):1623-31. PubMed ID: 22831478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2012 Jan; 4(1):2-16. PubMed ID: 22287289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The analytical challenges of anti-doping analysis.
    Harrison CR
    Anal Bioanal Chem; 2013 Dec; 405(30):9615-6. PubMed ID: 24043378
    [No Abstract]   [Full Text] [Related]  

  • 19. Science and the rules governing anti-doping violations.
    Bowers LD
    Handb Exp Pharmacol; 2010; (195):513-31. PubMed ID: 20020378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The list of prohibited substances and methods in sport: structure and review process by the world anti-doping agency.
    Mazzoni I; Barroso O; Rabin O
    J Anal Toxicol; 2011 Nov; 35(9):608-12. PubMed ID: 22080899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.